AAN 2021 - Physician's Weekly


Advertisement

AAN 2021

sNfL projects development of definite MS

In patients who experienced a first clinical demyelinating event, baseline levels of serum neurofilament light chain (sNfL), a biomarker of neural damage, were associated with conversion to McDonald 2005 multiple sclerosis (MS)....

The role of brain ATP abnormalities in MS disease progression

A 3-year prospective observational study investigating ATP changes in MS via T7 MRSI, comparing patients with and without vascular disease risk factors (VDRF), demonstrated that VDRF-positive patients had lower brain ATP rates...

Loading

Advertisement

For latest news and updates
Email-id is invalid